Chimerix(us:CMRX)

8.50

-0.12%

Updated on 2025-04-02

Open:8.50
Close:8.50
High:8.51
Low:8.50
Prev Close:8.51
Volume:1.75M
Turnover:14.86M
Turnover Ratio:1.86%
Shares:93.80M
MarketCap:797.33M

About Chimerix

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Company Name: Chimerix
Address: 2505 Meridian Parkway,Suite 100
Employees: 72
Fiscar Year: 12-31
IPO Date:
CIK: 1117480

View all SEC Filings

About

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Address:2505 Meridian Parkway,Suite 100

Market Movers